Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Kentucky

About this trial

This study is evaluating whether acupuncture may help reduce hot flashes in men receiving hormone therapy for prostate cancer. Hot flashes are a common side effect of androgen deprivation therapy (ADT) and may negatively affect sleep, mood, concentration, daily activities, and overall quality of life.

Participants enrolled in this study will receive acupuncture treatment over a defined treatment period. The study will assess changes in hot flash frequency, severity, and quality of life using patient questionnaires and symptom diaries. Participants will complete a daily hot flash diary during selected 7-day assessment periods and quality-of-life questionnaires during study visits.

The primary goal of this study is to determine whether acupuncture may improve hot flash symptoms and related quality of life in men undergoing treatment for prostate cancer.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients with history of prostate cancer with currently receiving hormone therapy or had received hormone therapy in the past two years

Hormone therapies may include androgen deprivation therapy ( ADT; e.g., leuprolide, degarelix, or relugolix) or androgen signaling inhibitors (e.g., enzalutamide, apalutamide, or darolutamide) or adrenal steroid synthesis inhibitor (e.g., abiraterone acetate).

Patients may also receive additional treatments such as chemotherapy, radioligand therapy or target therapy in combination with hormone therapy.

Reports hot flashes at least twice per day. Patients may already be taking medications for hot flashes. There is no limit on the number of hot flash medications they can be using.

Disqualifiers

Patients can't travel for acupuncture

Patients with high bleeding tendency as determined by PI

Trial design

Design model

Crossover

Treatments tested in this trial

  • Real Acupuncture

    Device

    The Real Acupuncture is administered at bilateral Large Intestine 4, Kidney 7, Kidney 3, and Gall Bladder 39 points using sterile single-use filiform needles. Needles are inserted approximately 20-25 mm with manipulation to achieve de qi sensation and retained for 30 minutes. Treatments are administered twice weekly for 6 weeks.

  • Sham Acupuncture

    Device

    The Sham Acupuncture administered at non-acupuncture points bilaterally using sterile single-use filiform needles. Needles are inserted approximately 4-5 mm without manipulation. Needles are retained for 30 minutes. Treatments are administered twice weekly for 6 weeks.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: Real AcupunctureExperimental treatment 1 intervention
Group B: Sham AcupunctureActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Change in Hot Flash Score

Weekly hot flash score will be calculated from a 7-day hot flash diary. Daily hot flash score is calculated as the number of hot flashes per day multiplied by the maximum severity score for that day. Weekly hot flash score is calculated as the sum of daily hot flash scores over 7 days. The primary outcome is the change in weekly hot flash score from baseline to Week 6.

Time frame
Baseline and week 6

Secondary outcomes

1

Change in Hot Flash Related Daily Interference Scale (HFRDIS) Score

Change in Hot Flash Related Daily Interference Scale (HFRDIS) total score from baseline. The HFRDIS is a validated 10-item patient-reported questionnaire assessing the impact of hot flashes on daily functioning and quality of life. Each item is scored from 0 to 10, with higher scores indicating greater interference from hot flashes.

Time frame
Baseline, Week 6, Week 16
2

Proportion of Participants Achieving ≥50% Reduction in Weekly Hot Flash Score

Proportion of participants achieving at least a 50% reduction in weekly hot flash score compared with baseline, based on 7-day hot flash diary assessments.

Time frame
Week 6 and Week 16
3

Change in Mean Daily Hot Flash Frequency

Change in the mean number of daily hot flashes recorded in the 7-day hot flash diary compared with baseline.

Time frame
Baseline, Week 6, Week 16

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.